- This event has passed.
BIOASTER exclusively licenses blood-based biomarkers for Tuberculosis diagnosis
27 May 2021 @ 8 h 00 min - 17 h 00 min
An international public-private collaborative study coordinated by BIOASTER has highlighted the value of blood-based transcriptomic biomarkers to improve early Tuberculosis (TB) diagnosis.